<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="29">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 16, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502695</url>
  </required_header>
  <id_info>
    <org_study_id>15-193</org_study_id>
    <nct_id>NCT02502695</nct_id>
  </id_info>
  <brief_title>A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)</brief_title>
  <official_title>A Prospective, Observational, Quality Improvement Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ethicon Global Surgery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dana-Farber Cancer Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study for participants who have been diagnosed with lung cancer and are
      receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The
      overall objective of this study is to develop a database to collect data on participants who
      are undergoing VATS lobectomy or segmentectomy for lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This database will be used as for quality improvement purposes. Furthermore, the database
      will help in collecting data in an organized fashion, which will help the investigators
      learn more about the details of the workup performed prior to the surgery, during the
      surgery, peri-operative management and early follow-up. The investigators hope that this
      database will help to determine a common guideline to perform VATS lobectomy or
      segmentectomy. By creating a common guideline for future treatment of VATS patients, the
      investigators predict the efficiency of the process will increase significantly without
      decreasing, and perhaps even improving, the quality of the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Readmissions rates within 30 days of the patient's surgery date</measure>
    <time_frame>30 Days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of post-operative complications within 30 days of the patient's surgery date</measure>
    <time_frame>30 Days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Total inpatient cost</measure>
    <time_frame>30 Days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in readmission rates between the two cohorts</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To compare current VATS-associated procedures with a set of best VATS-associated practives implemented across the participating study centers</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Cohort 1-VATS-associated best practices</arm_group_label>
    <description>Data to be collected will include demographic data and information about the pre-operative workup, surgical procedure, postoperative course and early discharge course for these patients.
After the last patient completes the 30-day post surgery follow-up, the investigators will determine a set of best practices to implement at each of the sites for the quality improvement initiative. During the assessment period, no patients will be enrolled into the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2-VATS-associated best practices</arm_group_label>
    <description>-Once the set of VATS-associated best practices, an additional cohort of approximately 200 patients will be enrolled and followed in a manner identical to the first cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VATS-associated best practices</intervention_name>
    <arm_group_label>Cohort 1-VATS-associated best practices</arm_group_label>
    <arm_group_label>Cohort 2-VATS-associated best practices</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants that will have VATS lobectomy and segmentectomy procedures for lung cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects

          -  Age â‰¥ 18 years

          -  Underwent a VATS lobectomy or segmentectomy procedure for lung cancer -- Note:
             patients with other malignancies are eligible if they have a primary cancer of the
             lung as defined above

        Exclusion Criteria:

          -  Subjects undergoing thoracotomy lobectomy or segmentectomy for lung cancer

          -  Subjects undergoing surgical procedures other than VATS lobectomy or segmentectomy
             for lung cancer
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott J. Swanson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Scott J. Swanson, MD</last_name>
    <phone>617-525-7532</phone>
    <email>SJSWANSON@PARTNERS.ORG</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julianne Barlow</last_name>
    <phone>617-525-8541</phone>
    <email>jbarlow1@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Georgetown University Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Blair Marshall, MD</last_name>
      <phone>202-444-1721</phone>
      <email>MBM5@gunet.georgetown.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sulakshana Seevaratnam</last_name>
      <phone>202-444-1721</phone>
      <email>Sulakshana.Seevaratnam@gunet.georgetown.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>WellStar Medical Group</name>
      <address>
        <city>Austell</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Miller, MD</last_name>
      <phone>678-331-6819</phone>
      <email>daniel.miller@wellstar.org</email>
    </contact>
    <contact_backup>
      <last_name>Pamela Yaun</last_name>
      <phone>678-331-6819</phone>
      <email>Pamela.Yaun@wellstar.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>North Shore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Howington, MD</last_name>
      <phone>847-570-1783</phone>
      <email>JHowington@northshore.org</email>
    </contact>
    <contact_backup>
      <last_name>Ujala Bokhar</last_name>
      <phone>847-570-1783</phone>
      <email>UBokhary@northshore.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott J. Swanson, MD</last_name>
      <phone>617-525-7532</phone>
      <email>SJSWANSON@PARTNERS.ORG</email>
    </contact>
    <contact_backup>
      <last_name>Julianne Barlow</last_name>
      <phone>617-525-8541</phone>
      <email>jbarlow1@partners.org</email>
    </contact_backup>
    <investigator>
      <last_name>Scott J. Swanson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Meyers, MD</last_name>
      <phone>314-747-6969</phone>
      <email>meyersb@wudosis.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Bell</last_name>
      <phone>314-747-6969</phone>
      <email>bellj@wudosis.wustl.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>February 5, 2016</lastchanged_date>
  <firstreceived_date>June 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dana-Farber Cancer Institute</investigator_affiliation>
    <investigator_full_name>Scott J. Swanson, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>VATS Lobectomy and Segmentectomy for Lung Cancer</keyword>
  <keyword>Lung Cancer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
